F Kronenberg

Author PubWeight™ 56.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinol Metab 2006 2.12
2 Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 2007 1.83
3 In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int 2007 1.61
4 [Calculated renal function: benefits and problems of the "Modification of Diet in Renal Disease" (MDRD) formula]. Dtsch Med Wochenschr 2005 1.39
5 Use of complementary and alternative medicine among women in New York City: a pilot study. J Altern Complement Med 2001 1.36
6 Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 2005 1.29
7 Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996 1.20
8 Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 2000 1.20
9 Thermoregulatory physiology of menopausal hot flashes: a review. Can J Physiol Pharmacol 1987 1.15
10 Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007 1.15
11 Use of complementary and alternative medicine among African-American and Hispanic women in New York City: a pilot study. J Am Med Womens Assoc 1999 1.08
12 Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas 1984 1.07
13 Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 2001 1.06
14 A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 1995 0.99
15 Use of complementary and alternative medicine among Dominican emergency department patients. Am J Emerg Med 2000 0.99
16 Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997 0.95
17 Familial juvenile hyperuricemic nephropathy: report on a new mutation and a pregnancy. Clin Nephrol 2009 0.90
18 Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions. J Lipid Res 2000 0.90
19 Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 1998 0.89
20 Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J Lipid Res 1997 0.87
21 Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997 0.87
22 Global Forum on Safety of Herbal and Traditional Medicine: July 7, 2001, Gold Coast, Australia. J Altern Complement Med 2001 0.85
23 Changes in neurotensin-like immunoreactivity during menopausal hot flashes. J Clin Endocrinol Metab 1985 0.84
24 Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation. Int J Obes (Lond) 2009 0.84
25 Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Oncol 2003 0.83
26 Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002 0.83
27 Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993 0.83
28 The value of plant collections in ethnopharmacology: a case study of an 85-year-old black cohosh (Actaea racemosa L.) sample. J Ethnopharmacol 2004 0.82
29 Analysis of formononetin from black cohosh (Actaea racemosa). Phytomedicine 2005 0.81
30 CAPD: a successful treatment in patients suffering from therapy-resistant congestive heart failure. Adv Perit Dial 1991 0.81
31 Concentrations of the atherogenic Lp(a) are elevated in FH. Eur J Hum Genet 1998 0.81
32 Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study. J Intern Med 2012 0.81
33 Dopamine D4 receptor polymorphism and idiopathic Parkinson's disease. Eur J Hum Genet 1999 0.80
34 Hormone-modulating herbs: implications for women's health. J Am Med Womens Assoc 1999 0.80
35 [How about the uncertainty in the haplotypes in the population-based KORA studies?]. Gesundheitswesen 2005 0.80
36 Ankle-brachial index and peripheral arterial disease. Gesundheitswesen 2005 0.79
37 Ethanolic extract of Actaea racemosa (black cohosh) potentiates bone nodule formation in MC3T3-E1 preosteoblast cells. Bone 2008 0.79
38 Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism. Hum Genet 1995 0.79
39 A simple score predicts future cardiovascular events in an inception cohort of dialysis patients. Kidney Int 2006 0.79
40 Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis. Nephrol Dial Transplant 1996 0.79
41 Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Wien Klin Wochenschr 1999 0.78
42 Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis 2001 0.78
43 The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases. Horm Metab Res 2007 0.78
44 Genetic variation in HDL-related genes and the association with cardiovascular disease: HDL particles as chameleons of lipoprotein metabolism. J Intern Med 2011 0.78
45 Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 2001 0.78
46 Wegener's granulomatosis and Henoch-Schönlein purpura in a family with hereditary C4 deficiency. Adv Exp Med Biol 1993 0.78
47 Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications. Diabetes Care 1996 0.78
48 Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease. Clin Nephrol 1997 0.77
49 Complementary and alternative medicine in women's health. Developing a research agenda. J Nurse Midwifery 1999 0.77
50 Evidence for a major gene accounting for mild elevation in LDL cholesterol: the NHLBI Family Heart Study. Ann Hum Genet 1999 0.77
51 Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int J Obes Relat Metab Disord 2004 0.77
52 Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up. Atherosclerosis 1999 0.77
53 Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol 1996 0.77
54 Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Kidney Int 1997 0.76
55 Neuropathic pain after femoropopliteal bypass surgery. J Vasc Surg 2004 0.76
56 Red clover (Trifolium pratense) for menopausal women: current state of knowledge. Menopause 2001 0.76
57 Recurrent abdominal pain caused by a toothpick in a CAPD patient. Adv Perit Dial 1991 0.76
58 Complement C4 phenotypes in patients with end-stage renal disease. Nephron 1996 0.76
59 Research on complementary and alternative therapies for cancer: issues and methodological considerations. J Am Med Womens Assoc 1999 0.76
60 Conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995 0.75
61 Exogenous and endogenous estrogens: an appreciation of biological complexity. Menopause 1999 0.75
62 Cyclosporin and serum lipids in renal transplant recipients. Lancet 1993 0.75
63 Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism. Metabolism 1999 0.75
64 Hereditary complete deficiency of the fourth component of complement: effects on the kidney. Clin Nephrol 1993 0.75
65 Renal artery thromboembolism and immunosuppressive therapy. Nephron 1996 0.75
66 Effect of fever on menopausal hot flashes. Maturitas 1992 0.75
67 Genetics and metabolism of lipoprotein(a) and clinical implications (Part 2). Wien Klin Wochenschr 1999 0.75
68 Lipoprotein(a) in renal disease: what we have, what we need, what we can forget. Nephrol Dial Transplant 1995 0.75
69 Gamma delta T lymphocytes in human glomerulonephritis. Nephrol Dial Transplant 1992 0.75
70 Impact of apolipoprotein(a) phenotypes on long-term renal transplant survival. J Am Soc Nephrol 2001 0.75